Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

UEI: LVEBAQTPN615CAGE: 557X3

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC is a federal contractor, registered under UEI LVEBAQTPN615 and CAGE code 557X3. It has been awarded $18,434,666 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Medicinal and Botanical Manufacturing, and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of Veterans Affairs, Department Of Health And Human Services, and Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

LVEBAQTPN615

CAGE Code

557X3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability CompanyManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Amneal Pharmaceuticals of New York, LLC specializes in the manufacturing of branded and generic pharmaceutical preparations, with deep expertise in complex oral solutions and controlled-substance formulations. The contractor’s core capabilities center on the production of high-precision, FDA-regulat...

Amneal Pharmaceuticals of New York, LLC specializes in the manufacturing of branded and generic pharmaceutical preparations, with deep expertise in complex oral solutions and controlled-substance formulations. The contractor’s core capabilities center on the production of high-precision, FDA-regulated drug products, including sodium oxybate (XYREM) oral solution and its generic equivalents, demonstrating proficiency in handling Schedule III controlled substances under strict cGMP standards. Their technical focus includes formulation development, stability testing, batch consistency, and regulatory-compliant manufacturing processes for specialty therapeutics, particularly in neurology and hematology. A key differentiator is their ability to execute rapid price adjustments and supply continuity for high-demand, low-volume medications, indicating advanced supply chain agility and regulatory responsiveness within the federal pharmaceutical ecosystem. The contractor maintains a consistent, long-term relationship with the Department of Veterans Affairs, delivering critical medications through Federal Supply Schedule contracts and direct procurement channels. Their work supports VA’s mission to ensure uninterrupted access to essential pharmaceuticals for veteran populations, particularly for chronic neurological conditions requiring precise dosing and controlled distribution. Primary industry focus is on NAICS 325412—pharmaceutical preparation manufacturing—where they serve as a specialized supplier of complex oral formulations, with vertical specialization in CNS and hematologic therapies. Their market positioning reflects a niche role as a reliable manufacturer of high-compliance, low-volume specialty drugs for government health systems. Amneal Pharmaceuticals of New York, LLC operates as a limited liability entity headquartered in Brookhaven, NY, with no active government certifications on record. Their geographic footprint is centered in New York, serving as a strategic manufacturing hub for federal pharmaceutical procurement, with a clear focus on sustaining supply for VA and other federal health agencies requiring assured access to regulated drug products.

Key Performance Metrics

Awards Count

117

All time

Active

1

Currently performing

Completed

116

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in AMNEAL PHARMACEUTICALS OF NEW YORK, LLC's top NAICS codes and agencies

NAICS: 332812
New
Federal
Area of Interest (AoI) – Metal Cleaning and Finishing Services
Solicitation # W911KF25SC002-AoI0016
The Army Contracting Command Anniston Army Depot is seeking innovative commercial solutions for depot-level metal cleaning, surface preparation, and finishing services for combat vehicle components. This requirement, issued under solicitation W911KF25SC002-AoI0016, encompasses chemical stripping, alkaline immersion cleaning, and abrasive media cleaning to remove paint, corrosion, scale, and carbon. The scope includes a wide array of plating and coating processes such as anodizing, chromate conversion, black oxide, electroless nickel, hard chrome, zinc, tin, copper, and phosphate. The government anticipates utilizing a Multiple Award Task Order Contract structure to ensure technical redundancy and coverage. Key performance requirements include a strict seven-working-day turnaround time and the contractor's responsibility for the secure pick-up and delivery of parts to and from the depot in Alabama. Offerors must demonstrate significant facility capabilities, including specific tank and oven dimensions, crane clearances, and the capacity to handle high-volume part streams of varying sizes. A rigorous quality assurance approach is mandatory, requiring the ability to perform various ASTM and MIL-SPEC tests, such as salt spray, adhesion, and hydrogen embrittlement, either in-house or through certified laboratories. Evaluation will be based on technical feasibility, the safety and efficiency of cleaning methods, innovation in eco-friendly processing, and the robustness of quality control systems. Additionally, the government will assess the offeror's track record with hazardous material management and compliance with environmental regulations. Interested parties must submit a written Solution Brief by October 28, 2026, including a Rough Order of Magnitude or unit pricing structure for evaluation.
Department Of Defense

POSTED

about 10 hours ago

DEADLINE

in 8 days
View Details